Back to Search
Start Over
Stopping disease-modifying treatments in multiple sclerosis: a meta-analysis with meta-regression
- Publication Year :
- 2023
- Publisher :
- Open Science Framework, 2023.
-
Abstract
- We aim at conducting a quantitative synthesis (meta-analysis) of the currently available real world evidence on discontinuation of disease-modifying treatments (DMTs) in patients with multiple sclerosis (MS), focusing on platform self-injectable and oral DMTs, i.e. interferon beta, glatiramer acetate, dimethyl fumarate, teriflunomide. We will explore: (1) the event rates for relapses and disability accrual after stopping platform DMTs; (2) the main determinants (moderators) for increased rates of relapse and disability accrual after stopping platform DMTs. We do not include studies about discontinuation of high-efficacy DMTs, i.e. monoclonal antibodies and sphingosine-1-phospate (S1P) receptors modulators whose discontinuation is commonly driven by safety issues and is freqeuntly associated with huge reactivation of disease activity (rebound).
- Subjects :
- Medical Sciences
FOS: Clinical medicine
Medicine and Health Sciences
Neurosciences
Subjects
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi...........5538c4cdd8fa0fc6f0677804d246faba
- Full Text :
- https://doi.org/10.17605/osf.io/xu2d3